Envirotainer takes another step in its journey of supporting global access of pharmaceuticals by expanding its flagship innovation RelEye

Envirotainer, the specialist in temperature-sensitive pharmaceutical shipments, has now completed its flagship product family with the launch of the RelEye RKN unit. The container meets the rising demand for small, lightweight, and connected temperature-controlled ULD solutions.

The RelEye RKN is the lightest of its class, reducing CO2 emissions per shipment, improving sustainability metrics and supporting pharma companies to meet their net zero goals. Additionally, the unit features an increased loading height, allowing for more products per shipment. This design innovation makes pharmaceutical deliveries more cost-effective while further supporting sustainability targets.

Designed to meet the strictest requirements in pharmaceutical air freight, the integrated real-time live monitoring enables a unique insight into product condition, location, and progress of the shipment. This visibility is offered alongside 24/7 support from the Control Tower that will follow every move, ready to respond within minutes to any critical event. With a market leading autonomy of +130 hours (over 5 days), the 1 pallet RelEye RKN protects cargo for longer, even in the event of unforeseen delays or supply chain disruptions.

“We are committed to bringing the most reliable and innovative solutions to market.” says David Simonsson, CEO at Envirotainer. “Our new RelEye RKN enhances the safety of transporting lifesaving pharmaceuticals worldwide. With six airlines already approving it for use, we are collaborating with pharmaceutical companies and logistics providers to support their qualification process, helping them integrate it seamlessly into their cold chain operations.”